Wellgistics Health Inc. (WGRX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Wellgistics Health Inc.

    NASDAQ: WGRX · Real-Time Price · USD
    0.68
    -0.12 (-15.13%)
    At close: Oct 03, 2025, 3:59 PM
    0.69
    1.53%
    After-hours: Oct 03, 2025, 07:49 PM EDT

    Wellgistics Health Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
    Revenue
    		 7.79M 10.86M -16.05M 15.8M 10.44M 7.94M 34.37M n/a n/a
    Cost of Revenue
    		 7.29M 10.17M -14.85M 15.06M 9.04M 7.12M 31.6M n/a n/a
    Gross Profit
    		 505.75K 692.64K -1.2M 745.6K 1.4M 820.11K 2.77M n/a n/a
    Operating Income
    		 -5.5M -31.35M 530.46K -2.91M -2.29M -1.49M -10.32M -903.31K -428.76K
    Interest Income
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Pretax Income
    		 -6.67M -32.43M 355.29K -3.05M -2.38M -1.77M -11.8M -903.31K -428.76K
    Net Income
    		 -6.67M -32.43M 355.29K -3.05M -2.38M -1.77M -11.8M -903.31K -428.76K
    Selling & General & Admin
    		 5.2M 31.24M 666.08K 2.46M 1.83M 1.84M 8.3M 903.31K 428.76K
    Research & Development
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Expenses
    		 802.8K 802.87K -2.39M 1.19M 1.85M 467.3K 4.79M n/a n/a
    Operating Expenses
    		 6.01M 32.04M -1.73M 3.65M 3.68M 2.31M 13.09M 903.31K 428.76K
    Interest Expense
    		 1.18M 1.09M -343.32K 357.5K 518.26K 299.03K 1.58M n/a n/a
    Selling & Marketing Expenses
    		 343.38K 65.22K n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 13.29M 42.21M -16.58M 18.71M 12.72M 9.42M 44.69M -903.31K -428.76K
    Income Tax Expense
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 61.77M 51.92M 51.94M 51.94M 51.94M 48.86M 46.79M 51.94M 51.94M
    Shares Outstanding (Diluted)
    		 61.77M 51.92M 51.94M 51.94M 51.94M 48.86M 46.79M 51.94M 51.94M
    EPS (Basic)
    		 -0.11 -0.62 -0.08 -0.04 -0.01 -0.04 -0.25 -0.02 -0.01
    EPS (Diluted)
    		 -0.11 -0.62 -0.08 -0.04 -0.01 -0.04 -0.25 -0.02 -0.01
    EBITDA
    		 -4.69M -30.53M 659.2K -1.51M -11.89K -1.01M -5.43M -903.31K -428.76K
    EBIT
    		 -5.49M -31.34M 11.96K -2.7M -1.87M -1.48M -10.22M -903.31K -428.76K
    Depreciation & Amortization
    		 802.8K 802.87K 647.24K 1.19M 1.85M 467.3K 4.79M n/a n/a

    Add to Watchlist